Skip to main content

Table 1 Background characteristics

From: Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study

 

CFS patients

Healthy controls

P value

Count—no.

120

68

 

Gender—no. (%)

 Male

32 (27)

22 (32)

0.408

 Female

88 (73)

46 (68)

 

Ethnicity—no. (%)

 Scandinavian

118 (98)

62 (91)

0.027

 Not Scandinavian

2 (1.7)

6 (8.8)

 

Age—years, mean (SD)

15.4 (1.6)

15.1 (1.6)

0.179

Body mass index—kg/m2, mean (SD)

21.5 (4.2)

20.6 (3.7)

0.131

Experienced menarche (females only)—no. (%)

 No

11 (13)

5 (19)

0.411

 Yes

75 (87)

21 (81)

 

Days since last menstrual bleeding (females only)—median (IQR)

15 (15)

16 (14)

0.884

Disease duration—months, median (IQR)

18 (14)

n.a.

n.a.

Depressive symptom score—mean (SD)

17 (10)

6 (8)

<0.001

Fatigue score—mean (SD)

19 (6)

9 (5)

<0.001

Steps per day—mean (SD)

4662 (2386)

10,293 (3716)

<0.001

Adherence to CDC diagnostic criteria—no. (%)

 No

29 (25)

n.a.

n.a.

 Yes

88 (75)

n.a.

 

Adherence to Canada diagnostic criteria—no. (%)

 No

69 (60)

n.a.

n.a.

 Yes

46 (40)

n.a.

 
  1. CFS chronic fatigue syndrome, SD standard deviation, IQR interquartile range, n.a. not applicable